Pharmaceuticals & Biotechnology

GlaxoSmithKline Pharmaceuticals Limited

ISIN: INE159A01016 · Data as of Sep 2026
Share: WhatsApp ✕ X
Search another stock:
Active Funds Holding
51
vs Last Month
-2 funds
Total Value
₹2,250.66 Cr
Avg Weight
1.26%
New Entries
8
Exits
10
ℹ️ Index funds and ETFs are excluded. Only actively managed funds reflect genuine fund manager decisions.
Mid Cap Rank #221
₹22.05 K Cr
Avg Mkt Cap · Jan-Jun 2023 (3yr ago)
→
₹40.59 K Cr
Avg Mkt Cap · Jan-Jun 2026 (latest)
+84.1%
3yr change
SEBI · AMFI Market Cap List
📋 What Changed This Month GlaxoSmithKline Pharmaceuticals Limited is currently held by 51 active mutual funds with total exposure of ₹2,250.66 Cr. This month 8 funds entered and 10 funds exited. Bandhan Healthcare Fund - Direct Plan - Growth has the highest allocation at 3.39%. ↓ Scroll down for full fund list and monthly changes.
Trend

How Has Fund Coverage Changed — Last 5 Months?

Month Funds AUM (Cr) AMCs Status
Sep 2026 REFERENCE 51 ₹2,251 48 / 49
Aug 2026 53 ₹2,809 49 / 49 ✅ Complete
Jul 2026 49 ₹2,224 49 / 49 ✅ Complete
Jun 2026 48 ₹1,923 49 / 49 ✅ Complete
May 2026 42 ₹1,633 49 / 49 ✅ Complete

📌 Portfolio changes below are based on Sep 2026 data — the most complete month with 48 AMCs we cover uploaded.

This Month

What Changed in the Portfolio — Sep 2026?

Note: Index funds and ETFs are excluded from this analysis. Their holdings change due to index rebalancing, not active fund manager decisions, and do not reflect genuine conviction buys or exits.

By Category

Which Fund Categories Hold This Stock?

Category Funds Avg Weight Distribution
Equity 20 1.24%
Mid Cap 10 1.24%
Flexi Cap 4 0.89%
Multi Asset 4 0.8%
Multi Cap 3 1.28%
ELSS 3 1.43%
Dividend Yield 2 2.42%
Balanced Advantage 2 1.5%
Small Cap 2 1.21%
Aggressive Hybrid 1 1.74%
All Holdings

Which 51 Active Funds Hold GlaxoSmithKline Pharmaceuticals Limited?

Filter:
Fund ↕ Category ↕ Weight ↕ Value ↕ Change ↕
Bandhan Healthcare Fund - Direct Plan - Growth
Bandhan Mutual Fund
Equity 3.39% ₹11.08 Cr -0.29%
Baroda BNP Paribas Dividend Yield Fund
Baroda BNP Paribas Mutual Fund
Dividend Yield 3.28% ₹17.45 Cr —
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option
Nippon India Mutual Fund
Equity 3.11% ₹285.09 Cr -0.2%
BAJAJ FINSERV MULTI CAP FUND - DIRECT - GROWTH
Bajaj Finserv Mutual Fund
Multi Cap 2.65% ₹43.56 Cr -0.19%
Bajaj Finserv Balanced Advantage Fund-Direct Plan-Growth
Bajaj Finserv Mutual Fund
Balanced Advantage 2.64% ₹31.86 Cr -0.11%
The Wealth Company Large & Mid Cap Fund
The Wealth Company Mutual Fund
Mid Cap 2.22% ₹2.41 Cr -0.16%
BAJAJ FINSERV ELSS TAX SAVER FUND - DIRECT - GROWTH
Bajaj Finserv Mutual Fund
ELSS 2.13% ₹1.88 Cr -0.12%
DSP Quant Fund - Direct Plan - Growth
DSP Mutual Fund
Equity 2.05% ₹14.54 Cr -0.34%
ICICI Prudential Quant Fund Direct Plan Growth
ICICI Prudential Mutual Fund
Equity 2.04% ₹3.33 Cr -0.13%
Helios Mid Cap Fund - Direct Plan - Growth Option
Helios Mutual Fund
Mid Cap 1.99% ₹46.63 Cr -0.31%
Kotak ESG Exclusionary Strategy Fund - Direct Plan - Growth Option
Kotak Mutual Fund
Equity 1.82% ₹12.46 Cr -0.03%
Tata Aggressive Hybrid Fund -Direct Plan- Growth Option
Tata Mutual Fund
Aggressive Hybrid 1.74% ₹69.23 Cr -0.13%
BARODA BNP PARIBAS Mid Cap Fund - Direct Plan - Growth Option
Baroda BNP Paribas Mutual Fund
Mid Cap 1.69% ₹42.42 Cr -0.07%
THE WEALTH COMPANY FLEXI CAP FUND
The Wealth Company Mutual Fund
Flexi Cap 1.67% ₹3.98 Cr -0.05%
BAJAJ FINSERV HEALTHCARE FUND - DIRECT - GROWTH
Bajaj Finserv Mutual Fund
Equity 1.63% ₹6.59 Cr -0.16%
Explore More
← Stock Search Top Stocks by MF Conviction Fund Directory AMC AAUM Rankings Market Cap Categories

Data source: Official AMFI monthly portfolio disclosures. Updated every month. Index funds and ETFs excluded. Disclaimer: This is not investment advice. Consult a SEBI-registered advisor before investing.